Fennec Pharmaceuticals (FENC) Total Debt (2010 - 2022)
Fennec Pharmaceuticals' (FENC) quarterly Total Debt came in at $25.0 million in Q4 2022, up 265.87% YoY from $6.8 million in Q4 2021, and little changed on a QoQ basis from $25.0 million in Q3 2022.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Total Debt (2010 - 2022) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 2 years of Total Debt data on file, last reported at $25.0 million in Q4 2022.
- Quarterly Total Debt rose 265.87% year-over-year to $25.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $25.0 million (up 265.87% YoY) and the FY2022 annual result came in at $25.0 million, up 265.87% from the prior year.
- Total Debt was little changed at $25.0 million in Q4 2022, from $25.0 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $25.0 million in Q3 2022 to a low of $1.8 million in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 591.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.07 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 9.34 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 25.00 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 7.00 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 2.00 Mn |
| Dec 31, 2017 | 167.00 Mn |
| Sep 30, 2017 | 373,000.00 |
| Jun 30, 2017 | 190,000.00 |
| Mar 31, 2017 | 71,000.00 |
| Dec 31, 2016 | 33,000.00 |
| Sep 30, 2016 | 37,000.00 |
| Jun 30, 2016 | 56,000.00 |
| Mar 31, 2016 | 39,000.00 |
| Dec 31, 2015 | 82,000.00 |
| Sep 30, 2015 | 93,000.00 |
| Jun 30, 2015 | 309,000.00 |
| Mar 31, 2015 | 694,000.00 |
| Dec 31, 2014 | 1.32 Mn |